Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Rigel Pharmaceuticals (NQ: RIGL )

3.260 USD -0.060 (-1.81%)
Official Closing Price Updated: 5:57 PM EDT, Apr 9, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Rigel Pharmaceuticals

< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Peek Under The Hood: XBI Has 65% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Rigel Announces Closing of Strategic Collaboration with Lilly
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the successful closing of its license agreement with Eli Lilly and Company (Lilly), following the expiration of the waiting period under the... 
From PR Newswire
Thinking about buying stock in Rigel Pharmaceuticals, AMC Entertainment, Vir Biotechnology, Oncolytics Biotech, or Senseonics Holdings?
InvestorsObserver issues critical PriceWatch Alerts for RIGL, AMC, VIR, ONCY, and SENS. 
From PR Newswire
Rigel Announces Completion of Patient Enrollment for NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients
Topline data expected in April 2021 
From PR Newswire
8 Biotech Penny Stocks for Investors to Watch
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Low-priced biotechs have sold off recently, but there could still be... 
Tags Penny Stocks RIGL TAK
From InvestorPlace
Analysts Anticipate XBI Will Reach $214
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Rigel Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
- Fourth quarter total revenues of $18.5 million; full year total revenues of $108.6 million 
From PR Newswire
The Daily Biotech Pulse: Roxadustat Delay For FibroGen, AstraZeneca, Decision Day For KemPharm, NanoViricides Jumps On COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags MORF LHDX Earnings
From Benzinga
Earnings Scheduled For March 2, 2021
Companies Reporting Before The Bell • Kopin (NASDAQ:KOPN) is expected to report quarterly loss at $0.01 per share on ... 
Tags CHFS MCRB TGT
From Benzinga
The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and ... 
Tags AGRX BNTX ANGN
From Benzinga
Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2020 Financial Results and Business Update
Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that it will report its fourth quarter and year end 2020 financial results after market close on Tuesday, March 2, 2021. Rigel senior... 
From PR Newswire
3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring
Here's why this stock's big run-up in recent months could be just the beginning. 
Tags LLY Market News RIGL
From Motley Fool
The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ONTX Guidance Penny Stocks
From Benzinga
88 Biggest Movers From Yesterday
Gainers HighCape Capital Acquisition Corp. (NASDAQ: CAPA) shares jumped 115.9% to close at $22.41 on Thursday. Quantum-Si ... 
Tags TYHT TTNP MOSY
From Benzinga
RIGL Stock: Why Rigel Pharmaceuticals Is Climbing Today
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>A newly announced deal between Rigel Pharmaceuticals and sector behemoth... 
Tags NASDAQ:RIGL,NYSE:LLY, LLY RIGL
From InvestorPlace
Why Rigel Pharmaceuticals Stock Is Jumping Today
The company is teaming up with Eli Lilly on the development of a promising immune disease drug. 
Tags Market News RIGL LLY
From Motley Fool
60 Stocks Moving In Thursday's Mid-Day Session
Gainers Greenland Technologies Holding Corp (NASDAQ: GTEC) shares jumped 134% to $17.66 following news of a deal with South China ... 
Tags Biotechnology TCS ELTK
From Benzinga
Lilly Strikes Licensing Deal With Rigel In Push Toward Neurological, Immunological Therapies
Eli Lilly And Co (NYSE: LLY) announced a licensing deal Thursday with smaller biopharma Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) that ... 
Tags Trading Ideas LLY DNLI
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET Thursday, 94 stocks made new 52-week highs. Interesting Facts: JPMorgan Chase (NYSE:JPM) ... 
Tags RAVN VIAC VINO
From Benzinga
Penny Stocks To Buy With Analysts Targeting 76%-209% Upside
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Thinking about buying stock in Avinger, Rigel Pharmaceuticals, Vistagen Therapeutics, Bio-Path, or Corvus Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for AVGR, RIGL, VTGN, BPTH, and CRVS. 
From PR Newswire
The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags IBB PAVM AVNS
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Avinger (NASDAQ:AVGR) stock rose 58.57% to $2.68 during Thursday's pre-market session. The market value of ... 
Tags Movers HOTH RWLK
From Benzinga
40 Stocks Moving in Thursday's Pre-Market Session
Gainers Heritage Global Inc. (NASDAQ: HGBL) shares rose 153.3% to $7.80 in pre-market trading. Heritage Global Partners, and a ... 
Tags Top Gainers Penny Stocks Trading Ideas
From Benzinga
Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treatment of Immunological and Neurodegenerative Diseases
- Lilly will obtain an exclusive worldwide license to Rigel's RIPK1 inhibitors, including Rigel's Phase 2-ready molecule R552, in all indications 
From PR Newswire
3 Penny Stocks Outpacing The Market This Week, Time To Buy?
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Top Penny Stocks To Watch Heading Into February 2021
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
Study has the potential to facilitate a filing for Emergency Use Authorization (EUA) 
From PR Newswire
Rigel Pharmaceuticals Provides Business Update
TAVALISSE® preliminary 2020 net product sales of approximately $61.7 million, a year-over-year increase of 41% 
From PR Newswire
XBI's Holdings Could Mean 41% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
37 38 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.